Triptans versus analgesics.
OBJECTIVE
To retrospectively assess patient preferences between triptans and analgesics in treating migraine headache.


METHODS
The study assessed patient preferences for triptans versus commonly used migraine analgesic preparations. Over a 3-month period, 663 patients with migraine between the ages of 17 and 62 years completed an office-based survey.


RESULTS
Most patients preferred a treatment regimen that included either a triptan alone (52%) or a triptan with an analgesic medication within 1 hour (18%). Overall, 70% of patients who had been given triptans in the past chose to continue to use them, either alone or with an analgesic. Patients who preferred analgesics alone comprised 21% of the total. Nine percent preferred not to take either triptans or analgesic medications. Among the patients who preferred triptans, 62% stated that increased efficacy was the primary reason for their preference. Thirty percent cited both efficacy and decreased adverse events. The remaining 8% believed that decreased adverse events was the basis for their preference.


CONCLUSIONS
Despite cost and other limitations of triptans, most patients prefer them over nontriptan medications. Enhanced efficacy was the main reason for choosing triptans over analgesics.
Robbins
Lawrence
L
Department of Neurology, Rush Medical College, Chicago, IL 60062, USA.
D000293:Adolescent; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D017060:Patient Satisfaction; D012189:Retrospective Studies; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use
D000700:Analgesics; D017366:Serotonin Receptor Agonists; D018170:Sumatriptan